92 related articles for article (PubMed ID: 21277329)
1. High-content screening to distinguish between attachment and post-attachment steps of human cytomegalovirus entry into fibroblasts and epithelial cells.
Ibig-Rehm Y; Götte M; Gabriel D; Woodhall D; Shea A; Brown NE; Compton T; Feire AL
Antiviral Res; 2011 Mar; 89(3):246-56. PubMed ID: 21277329
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
Soroceanu L; Akhavan A; Cobbs CS
Nature; 2008 Sep; 455(7211):391-5. PubMed ID: 18701889
[TBL] [Abstract][Full Text] [Related]
3. Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.
Luganini A; Caposio P; Landolfo S; Gribaudo G
Antimicrob Agents Chemother; 2008 Mar; 52(3):1111-20. PubMed ID: 18180342
[TBL] [Abstract][Full Text] [Related]
4. CD147 Promotes Entry of Pentamer-Expressing Human Cytomegalovirus into Epithelial and Endothelial Cells.
Vanarsdall AL; Pritchard SR; Wisner TW; Liu J; Jardetzky TS; Johnson DC
mBio; 2018 May; 9(3):. PubMed ID: 29739904
[TBL] [Abstract][Full Text] [Related]
5. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.
Luganini A; Giuliani A; Pirri G; Pizzuto L; Landolfo S; Gribaudo G
Antiviral Res; 2010 Mar; 85(3):532-40. PubMed ID: 20083141
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications.
Revello MG; Gerna G
Rev Med Virol; 2010 May; 20(3):136-55. PubMed ID: 20084641
[TBL] [Abstract][Full Text] [Related]
7. Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.
Bodaghi B; Slobbe-van Drunen ME; Topilko A; Perret E; Vossen RC; van Dam-Mieras MC; Zipeto D; Virelizier JL; LeHoang P; Bruggeman CA; Michelson S
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2598-607. PubMed ID: 10509655
[TBL] [Abstract][Full Text] [Related]
8. The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication.
Zhang H; Niu X; Qian Z; Qian J; Xuan B
J Med Virol; 2015 Dec; 87(12):2135-44. PubMed ID: 26058558
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus.
Dal Pozzo F; Andrei G; Daelemans D; Winkler M; Piette J; De Clercq E; Snoeck R
J Virol Methods; 2008 Jul; 151(1):66-73. PubMed ID: 18490063
[TBL] [Abstract][Full Text] [Related]
10. Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry.
Shoup M; Ourahmane A; Ginsburg EP; Farrell NP; McVoy MA
Antiviral Res; 2020 Dec; 184():104957. PubMed ID: 33132195
[TBL] [Abstract][Full Text] [Related]
11. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate.
Compton T; Nowlin DM; Cooper NR
Virology; 1993 Apr; 193(2):834-41. PubMed ID: 8384757
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus productively infects adrenocortical cells and induces an early cortisol response.
Trevisan M; Matkovic U; Cusinato R; Toppo S; Palù G; Barzon L
J Cell Physiol; 2009 Dec; 221(3):629-41. PubMed ID: 19688782
[TBL] [Abstract][Full Text] [Related]
13. Transmission of cell-associated human cytomegalovirus isolates between various cell types using polymorphonuclear leukocytes as a vehicle.
Braun B; Sinzger C
Med Microbiol Immunol; 2021 Aug; 210(4):197-209. PubMed ID: 34091753
[TBL] [Abstract][Full Text] [Related]
14. PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway.
Vanarsdall AL; Wisner TW; Lei H; Kazlauskas A; Johnson DC
PLoS Pathog; 2012 Sep; 8(9):e1002905. PubMed ID: 23028311
[TBL] [Abstract][Full Text] [Related]
15. Screening of small-molecule compounds as inhibitors of HCV entry.
Yang JP; Zhou D; Wong-Staal F
Methods Mol Biol; 2009; 510():295-304. PubMed ID: 19009270
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
[TBL] [Abstract][Full Text] [Related]
17. A cell free protein fragment complementation assay for monitoring the core interaction of the human cytomegalovirus nuclear egress complex.
Schnee M; Wagner FM; Koszinowski UH; Ruzsics Z
Antiviral Res; 2012 Jul; 95(1):12-8. PubMed ID: 22580129
[TBL] [Abstract][Full Text] [Related]
18. Spatial patterns of protein expression in focal infections of human cytomegalovirus.
Lam V; Boehme KW; Compton T; Yin J
Biotechnol Bioeng; 2006 Apr; 93(6):1029-39. PubMed ID: 16506244
[TBL] [Abstract][Full Text] [Related]
19. Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo.
Sinzger C; Bissinger AL; Viebahn R; Oettle H; Radke C; Schmidt CA; Jahn G
J Infect Dis; 1999 Oct; 180(4):976-86. PubMed ID: 10479121
[TBL] [Abstract][Full Text] [Related]
20. A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells.
Stegmann C; Hochdorfer D; Lieber D; Subramanian N; Stöhr D; Laib Sampaio K; Sinzger C
PLoS Pathog; 2017 Apr; 13(4):e1006273. PubMed ID: 28403220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
